Skip to main content
EOLS logo

EOLS · Evolus, Inc. · Investor Relations

Track EOLS — free
$7.35 -0.17 (-2.26%) At close · Oct 30 Q2 2026 earnings call transcript
Market Cap
$496.70M
Shares
66.05M
Volume · Oct 30 793.61K Avg daily vol (3M) 892.94K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-04 21:30 UTC Q3 2026 Evolus, Inc. Earnings Conference Call Earnings call
2026-11-11 19:00 UTC Stifel 2026 Healthcare Conference Conference
2026-11-11 19:00 UTC The Stifel Healthcare Conference Conference

Recent news

Date Headline
2026-10-28 Evolus to Participate in Upcoming Investor Conferences in New York and London
2026-10-21 Evolus to Report Third Quarter Financial Results on November 4, 2026
2026-10-14 Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
2026-10-01 Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
2026-08-05 Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
2026-08-04 Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
2026-07-22 Evolus to Report Second Quarter Financial Results on August 5, 2026
2026-07-10 Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-08 Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality
2026-05-19 Evolus to Participate in The Jefferies Global Healthcare Conference
2026-05-11 Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe
2026-05-04 Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
2026-04-14 Evolus to Report First Quarter Financial Results on May 4, 2026
2026-03-31 Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference
2026-03-20 Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-03-03 Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability<sup>1</sup> Beginning in 2026
2026-02-25 Evolus to Participate in The Leerink Partners Global Healthcare Conference
2026-02-17 Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026
2026-02-13 Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-01-09 Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue

Provides 2026 Net Revenue Guidance and Maintains Projection for Full-Year 2026 Profitability1 Preliminary Unaudited Net Revenue of $88.6 Million to $90.6 Million for the Fourth Quarter 2025, Representing 12% to 15% Growth Over the Prior Year; Company Reaffirms an Important Milestone of Positive Non-GAAP Operating Income of $5 Million to $7 Million for Q4 2025 Preliminary Unaudited Net Revenue of $295.5 Million to $297.5 Million for the Full-Year 2025, Representing 11% to 12% Growth Over the Prior Year 2026 Net Revenue Guidance of $327.0 Million to $337.0 Million, Which Represents 11% to 13% Growth from Preliminary Unaudited 2025 Results; Company Remains on Track to Achieve Sustainable Annual Profitability1 Beginning in 2026 Updates 2028 Long-Term Financial Outlook to Reflect Total Net Revenue of $450 Million to $500 Million, Representing a Three-Year CAGR of 15% to 19%, and Non-GAAP Operating Income Margins of 13% to 15% for 2028 Evolus, Inc. (NASDAQ: EOLS), a global performance

Past events

Date Event Type
2026-08-05 Q2 2026 Evolus, Inc. Earnings Conference Call Earnings call
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-05-04 Q1 2026 Evolus, Inc. Earnings Conference Call Earnings call
2026-04-14 Needham Virtual Healthcare Conference Conference
2026-03-11 Leerink Global Healthcare Conference Conference
2026-03-03 Q4 2025 Evolus, Inc. Earnings Conference Call Earnings call
2025-11-11 Stifel 2025 Healthcare Conference Conference
2025-11-05 Q3 2025 Evolus, Inc. Earnings Conference Call Earnings call
2025-08-05 Q2 2025 Evolus, Inc. Earnings Conference Call Earnings call
2025-05-07 Q1 2025 Evolus, Inc. Earnings Conference Call Earnings call
2025-04-08 24th Annual Needham Virtual Healthcare Conference Conference
2025-03-12 Barclays 27th Annual Global Healthcare Conference Conference
2025-03-11 Leerink Partners Global Biopharma Conference Conference
2025-03-04 Q4 2024 Evolus, Inc. Earnings Conference Call Earnings call
2025-02-27 TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit Event
2024-11-19 Stifel 2024 Healthcare Conference Conference
2024-11-06 Q3 2024 Evolus, Inc. Earnings Conference Call Earnings call
2024-09-12 Evolus Investor Day Presentation
2024-08-13 Canaccord Genuity 44th Annual Growth Conference Conference
2024-07-31 Q2 2024 Evolus, Inc. Earnings Conference Call Earnings call
2024-05-21 BNPP Exane’s Aesthetics Day Conference Conference
2024-05-07 Q1 2024 Evolus, Inc. Earnings Conference Call Earnings call
2024-04-09 23rd Annual Needham Virtual Healthcare Conference Conference
2024-03-13 The Barclays 26th Annual Global Healthcare Conference Conference
2024-03-12 The Leerink Partners Global Biopharma Conference 2024 Conference

Source: https://investors.evolus.com/overview/default.aspx

Key facts CIK 1570562 CUSIP 30052C107 13F (30d) 32 filings 32 filers Visit website Investor relations